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Abstract
Aloe plants have been suggested to be an important natural source of medical therapy agents
(including for cancer) for several years. Throughout the world, pharmaceutical companies and
institutions are struggling to isolate its most potent bioactive compounds as a primary means of using
its activities. Regardless of the species used, the extraction procedure selected or the lack of specific
compounds responsible for any given bioactivity, the fact is that we have been witnessing several
debates, disputes and a lot of conflicting results arising on the claimed anticancer properties of Aloe
species.
During the last decade, several reports demonstrated that a subgroup of matrix metalloproteinases
(MMPs) called gelatinases (MMP-2 and especially MMP-9), are largely responsible for colorectal
cancer progression/metastasis, suggesting that MMP inhibitors (MMPIs) may be a powerful tool to
reduce cancer invasion. Although Aloe’s activities suggest they might inhibit MMPs, no studies have
related their reported anticancer activity with MMPI activities.  Also, although approximately 500
species have been identified so far within the Aloe genus, A. vera is the most widely studied albeit
other species such as A. arborescens have also been reported to exhibit similar bioactivities. Hence,
the goal of the present study was to compare the anticancer potential of two Aloe species, A. vera and
A. arborescens and to ascertain if they are specific MMP-9 and/or MMP-2 inhibitors.
Different types of extraction were tested (100% (v/v) methanol, 50% (v/v) methanol and 100 mM
Tris-HCl buffer pH 7) and specific bioactive compounds (proteins, total phenolic compounds,
anthraquinones and total carbohydrates) were quantified and compared. Although there were a few
variations between species and between extractions, 50% (v/v) methanol was selected as the best
extraction procedure. Anticancer activities were measured in vitro using the wound healing model
assay in the human colon cancer cells HT29, and A. vera showed significantly higher inhibitory
potencial regarding wound closure. Furthermore, it was also evaluated their effects on gelatinase
activities, measured by gelatin zymography and the DQ gelatinase assay. When assessing the total
gelatinolytic activity, both species had a similar result of around 20% inhibition. Through the gelatin
zimography we demonstrated that both MMP-9 pro-form and active form were inhibited, but only the
MMP-2 pro form were inhibited, which corroborates the results obtained with the total gelatinolytic
activity assay. The gelatinolytic activity of MMP-9 showed that although both species have the
potencial to inhibit specifically this metalloproteinase, A. arborescens have a significantly higher
inhibitory effectiveness.
Overall, our data provided clear indication that A. arborescens and A. vera have indeed potential as
inhibitory agents in cancer therapy, being able to reduce colon cancer cell proliferation and invasion,
possibly via specific MMP-9 inhibition. A. arborescens appears to be a more effective cancer cell
invasion inhibitor than A. vera. Also, we observed that different types of extraction are important to
obtain higher amounts of bioactive compounds and also higher levels of bioactivities. This might be
due to a greater amount of extractable bioactive compounds such as anthraquinones. These results
open novel perspectives on the mode of action of Aloe species in cancer invasion and may provide
clues as to why there are so many conflicting results.
Keywords: Aloe, cancer, MMP-9, MMP-2, HT29
~ VII ~
Resumo
Desde a antiguidade que as espécies do género Aloe são consideradas como uma importante fonte
natural de compostos terapêuticos. Contudo, nas últimas décadas tem-se verificado um crescimento
rápido e exponencial do interesse popular nestas plantas. O Aloe barbadensis (mais vulgarmente
conhecido como Aloe vera) é, entre as espécies deste género, a mais reconhecida e popularizada
sendo-lhe atribuídas uma miríade de aplicações e indicações terapêuticas, muitas vezes não
fundamentadas cientificamente. Consequentemente, a nível mundial, tanto empresas como instituições
farmacêuticas procuram avidamente separar e identificar os compostos bioativos mais potentes entre
espécies de Aloe, como forma de isolar potenciais bioatividades para aplicar em fármacos ou em
produtos vendáveis. Contudo, tem surgido um grande debate entre a comunidade científica sobre o
verdadeiro valor terapêutico desta espécie; enquanto alguns trabalhos científicos advogam o seu
grande potencial, outros desacreditam totalmente os seus efeitos, alertando mesmo os seus eventuais
perigos para a saúde. Existem várias razões possíveis para justificar estas inconsistências nos estudos
publicados até à data. A. vera é a espécie mais utilizada e conhecida atualmente, sendo o elemento do
seu género mais amplamente estudado, apesar de outras espécies tais como A. arborescens e A. ferox
terem sido igualmente descritas como tendo bioatividades semelhantes ou mesmo superiores. Existe
também grande inconsistência em relação ao tipo de solventes a utilizar nas extrações, o que pode
influenciar a biodisponibilidade e quantidade de compostos ativos. Além disso, cada vez mais parece
evidente que a ação terapêutica das plantas de Aloe poderá estar associada a uma sinergia entre os
vários compostos bioativos presentes nas suas folhas e não apenas à ação de um único composto
isolado. Por tudo isto, existe ainda muito trabalho a realizar e muitas questões que deveriam ser
abordadas em relação a estas espécies.
Uma das aplicações mais conhecidas e procuradas do género Aloe é o seu potencial efeito anti-
tumoral. Vários estudos têm comprovado que existe de facto um efeito preventivo e inibidor de vários
tipos de tumores induzido pelos extratos e compostos de Aloe. Contudo, o mecanismo através do qual
estes efeitos são exercidos ainda não está totalmente esclarecido.
Durante a última década, vários estudos revelaram que existe um subgrupo de metaloproteinases de
matriz (MMPs), as gelatinases (MMP-2 e MMP-9), que estão envolvidas no processo de metastização.
Estes trabalhos têm demonstrado que os seus inibidores (MMPIs) poderão ser uma ferramenta muito
útil para reduzir a invasão tumoral. Estas enzimas (sobretudo a MMP-9) também estão fortemente
envolvidas em processos de cicatrização e de inflamação. Deste modo, o facto de os efeitos das plantas
de Aloe estarem associados simultaneamente a atividades cicatrizantes, anti-inflamatórias e anti-
tumorais sugere que poderão influenciar o mecanismo de ação da MMP-9 e da MMP-2. Contudo, até à
data, ainda não existem estudos que associem o potencial anti-tumoral das espécies de Aloe com uma
possível inibição das duas gelatinases Assim, neste contexto, no presente trabalho decidiu-se
determinar e comparar a atividade anti-tumoral de duas espécies do género Aloe bastante conhecidas,
A. vera e A. arborescens, avaliando o seu impacto no crescimento e na migração de células de
adenocarcinoma do cólon e determinando se estes efeitos estão ou não associados a alguma influência
na atividade das MMP-9 e/ou da MMP-2.
Foram primeiramente avaliadas as diferenças entre as duas espécies de Aloe, através da
caraterização de diferentes compostos com potencial bioativo já descritas para este género,
nomeadamente proteínas, compostos fenólicos, antraquinonas e hidratos de carbono totais. Foi
também objetivo testar diferentes métodos de extração e tentar compreender qual o melhor processo
de modo a obter o maior teor de compostos bioativos. Todos os compostos foram quantificados em
três tipos de extracção: aquosa (em tampão Tris-HCl), hidro-metanólica (50% (v/v) metanol) e
metanólica (100% (v/v) metanol).
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Os resultados mostraram que, apesar de o teor em compostos bioativos não ter variado de forma
marcada entre as duas espécies, A. vera apresentou um teor mais elevado em compostos fenólicos
totais, enquanto A. arborescens apresentou valores superiores em antraquinonas. Os resultados
comprovaram também que o método de extração não só influencia fortemente a quantidade de
compostos bioativos isolados, como também difere entre as duas espécies. Por exemplo, enquanto A.
vera mostrou de um modo geral um maior teor em compostos extraídos a 50% (v/v) metanol, no A.
arborescens estes valores variaram consoante os compostos determinados. Isto é de extrema
importância uma vez que muitos estudos utilizam apenas um tipo de extração, independentemente da
espécie e do composto a isolar, sendo raros os artigos que utilizam a extração hidro-metanólica.
Em segundo lugar, foi determinado o potencial anti-tumoral dos melhores extratos de Aloe em
células de adenocarcinoma do cólon humano (células HT29), utilizando os métodos padrão de
proliferação celular e de invasão celular. O trabalho efetuado mostrou que as duas espécies estudadas
apresentam de facto potencial para serem inibidoras do desenvolvimento tumoral, reduzindo tanto o
crescimento celular como a invasão por células HT29. A inibição do crescimento das células tumorais
foi dependente da dose e semelhante entre as duas espécies. Estes resultados permitiram ainda
selecionar uma concentração EC50, que foi utilizada nos estudos subsequentes. Nos estudos de
invasão tumoral, verificou-se que, apesar de as duas espécies terem tido atividades similares na
proliferação celular, na invasão A. arborescens revelou ser a espécie com maior atividade, atingindo
valores de inibição semelhantes ao conhecido inibidor de MMP-9, doxiciclina. Estes resultados
sugerem que as pequenas diferenças de compostos bioativos observadas anteriormente, nomeadamente
o maior teor em antraquinonas, poderão estar associados a um maior potencial de inibição por parte de
A. arborescens.
Uma vez que, segundo a literatura, uma maior inibição na invasão está normalmente associada a
uma redução na atividade das gelatinases MMP-9 e MMP-2, foi subsequentemente avaliada a
atividade destas duas enzimas no meio extracelular das células HT29, após exposição aos extratos de
cada uma das espécies de Aloe. Para tal, foi utilizado o método da DQ gelatina que avalia a atividade
gelatinolítica total e a zimografia de substrato, que separa as MMP-9 das MMP-2 num gel SDS-
PAGE, permitindo a avaliação da atividade específica de cada uma. Os resultados das atividades das
gelatinases corroboraram que os extratos das duas espécies possuem de facto capacidade de inibição
das gelatinases, mas com maior especificidade para a MMP-9 do que para a MMP-2. De forma a testar
se esta inibição ocorre por influência direta na enzima, foi ainda efetuado um ensaio de inibição
enzimática com uma MMP-9 comercial na presença da DQ gelatina. Ambas as espécies mostraram
inibir a gelatinase MMP-9. Contudo, o extrato de A. arborescens mostrou maior atividade inibitória
que o de A. vera. Não obstante, a inibição da MMP-9 não foi tão elevada como a verificada nas
zimografias do meio extracelular das células HT29. Deste modo, os resultados sugerem que poderão
existir outros mecanismos de ação que não apenas a inibição direta da enzima.
Em conclusão, o trabalho efetuado mostrou que as duas espécies estudadas de Aloe apresentam de
facto um potencial para serem inibidoras do desenvolvimento tumoral, inibindo tanto o crescimento
celular como a invasão. Os resultados mostram também que esta inibição pode estar relacionada com
uma redução específica da atividade da MMP-9 e da MMP-2.
Apesar de terem concentrações semelhantes das várias classes de compostos bioativos, A.
arborescens parece ser um inibidor da invasão tumoral mais eficaz do que A. vera. Isto pode ser
devido a uma maior quantidade de compostos bioativos individuais, como as antraquinonas presentes
em A. arborescens, ou à presença de compostos específicos ainda não identificados nessa espécie. Os
resultados aqui apresentados mostram igualmente que a utilização de espécies de Aloe, quer seja na
prevenção ou na terapia tumoral, deve ter sempre em consideração o tipo de extração, devendo esta
adaptar-se de acordo com a espécie e o objetivo em mente; de outro modo podem não ser obtidos os
resultados mais realistas e reveladores do verdadeiro potencial da espécie.
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De um modo geral, A arborescens parece ser uma alternativa mais eficaz do que A. vera no caso da
inibição e da invasão celulares, sugerindo um elevado potencial de utilização como coadjuvante em
terapias tumorais, ou ainda na prevenção da formação de metástases em tumores já estabelecidos. Uma
vez que a inibição direta das enzimas parece não ser o seu único mecanismo de ação, mais estudos
deveriam ser efetuados para determinar a sua toxicidade e efeitos. Não obstante, os resultados obtidos
neste trabalho abrem as portas para novos trabalhos sobre a inibição de MMPs por parte das espécies
de Aloe, chamando a atenção para a necessidade de uma reavaliação do tipo de metodologias de
extração utilizados, bem como as espécies utilizadas e respetivos alvos terapêuticos.
Palavras-chave: Aloe, cancro, MMP-9, MMP-2, HT29
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1 - Introduction
1.1 The Aloe genus:  century-old known medicinal plants
The genus Aloe has been one of the best known for
medicinal purposes in several cultures for millennia and its
uses are referred to as early as in Egyptian papyri or the
Materia Medica of Dioscorides (Fig.1.1) and the Colloquies
of Garcia de Orta [1, 2]. Nonetheless, it was not until the last
decades that public interest in Aloe species grew
tremendously, with such a vast array of proclaimed properties
and applications, ranging from burns, skin damage, edema,
pain and gastric ulcers, to cancer that it has been labeled a
“cure-all miracle” plant. This boosted the investigator’s
interest on this plant and consequently, a considerable
amount of research about the various components of Aloe
began to arise, aiming to find out more about their properties and to pinpoint specific compounds
which may be used/commercialized as pharmacological agents [3]. Indeed, Aloe extracts have been
reported to possess anti-inflammatory, anti-diabetes, cellular protection, restoration, and mucus-
stimulating activities, among others, which might be related to its broad-range effects [4- 7].
Today, Aloe barbadensis (herein referred to as Aloe vera) is unquestionably the most popular
species of Aloe used worldwide, often referred to as the one with the highest bioactivities in anecdotal
reports. However, there are approximately 500 Aloe species documented, from which only a marginal
fraction has recorded ethnomedicinal uses [8]. As a result of its huge medicinal demands and the
morphological similarities among several species, there is a high probability that certain species may
often be erroneously identified for different medicinal uses. So in addition to the increasing interest in
the phytochemical and pharmacological potential of Aloe, the regular evaluation and re-evaluation of
existing bodies of knowledge are deemed necessary to provide an up-to-date information while
identifying the current research gaps.  In Portugal, access to different Aloe species is difficult, as they
are mostly found in the African continent [8], but Instituto Superior de Agronomia (ISA) has the largest
collection of Aloe species in Europe, counting with more than 80 species, collecting species from
Africa, identifying new taxa and establishing and maintaining cultures in the ISA´s botanical gardens.
1.1.1 Anatomy
The genus Aloe belongs to the Xanthorrhoeaceae family and subfamily Asphodeloideae,
characterized by plants presenting a rosette of large and succulent leaves. The Aloe species are
relatively similar regarding their anatomy. All plants have boat-shaped fleshy leaves with spiny
margins, arranged in rosettes or spirals [9, 10]. These plants usually produce racemose inflorescences
with tubular flowers, with a yellow orange, pink or red color. They flower mainly during the winter
season and produce large quantities of small, air-borne seeds, although there are many species that can
also propagate asexually [9, 10]. Although Aloe plants are relatively similar in structure, they exhibit a
wide morphological variability and various growth forms [11], ranging in size from dwarf species, of
only a few cm high to giant, 20 m tree Aloes [9, 12].
The leaf structure of the Aloe plant can be separate into three different components, from the
exterior portion to the most interior: 1) a green rind or cuticle, with multiple layers interspersed with
chloroplasts, 2) a region composed by vascular bundles with three tubular structures, which secretes a
Figure 1.1 - Ancient Greek Dioscorides
recorded his use of Aloe to treat war
wounds as well as piles (Image: Vienna
Cod.med.gr.1, fol.15r/ONB)
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latex or sap when cut, and 3) an inner pulp or gel [13]. The gel or pulp comprises the major part of the
leaf’s volume and is composed by large thin-walled parenchyma cells responsible for the clear
mucilaginous aqueous extract obtained from this part of the plant [14, 15] (Fig.1.2). Carbohydrates
synthesized in excess are transported via phloem to these
cells which also store water, minerals and malic acid. Thus,
the parenchymal cells serve as a water and energy reservoir
for the plant. The latex (yellow substance visible in Figure
1.2) is restricted to the margins of the leaves, suggesting that
it may be a source of secondary metabolites [15]. Although
there are several articles highlighting the pytochemical
composition of Aloe vera, little is known about other species,
such as A. arborescens and A. ferox, which have also been
the target of several assays in the last years [16-19].
1.1.2 Reported groups of bioactive components and properties in the Aloe genus
According to Surjushe et al. (2008) [20] Aloe vera is by far the most thoroughly characterized
species within Aloe genus, contains many potentially active constituents: vitamins, enzymes, minerals,
sugars, lignin, saponins, salicylic acids and amino acids [5, 22, 27]. Many of these compounds are
responsible for some pharmacological activities described, such as aloin, Aloesin, Aloenin, Aloeresin
and Aloe-emodin, among others [8, 23]. It is known that these compounds differ greatly among species,
and some of them can be toxic and extremely allergenic [23, 24].
Below is a list of the main compounds present in A. vera:
1. Vitamins: vitamins A (β-carotene), C and E, which are antioxidants, are present in A. vera, which
also contains vitamin B12, folic acid, and choline. Antioxidant compounds aid organisms coping
with oxidative stress [7, 20, 21].
2. Enzymes: A. vera contains several enzymes such as alkaline phosphatase, amylase, bradykinase,
carboxypeptidase, catalase, cellulase, lipase, and peroxidase. Bradykinase helps to reduce
excessive inflammation when applied to the skin topically, while others help in the breakdown of
sugars and fats [7, 20].
3. Minerals: A. vera is a good dietary source of calcium, chromium, copper, selenium, magnesium,
manganese, potassium, sodium and zinc. These elements are essential for the proper functioning
of various enzyme systems in different metabolic pathways and a few also participate in the
organism’s antioxidants defenses [7, 20].
4. Sugars: A. vera provides essentially monosaccharides (glucose and fructose) and
polysaccharides: (glucomannans/polymannose). These are derived from the mucilage layer of the
plant and are known as mucopolysaccharides. The most prominent monosaccharide is mannose-
6-phosphate, and the most common polysaccharides are glucomannans [β-(1,4)-acetylated
mannan]. Acemannan, a prominent glucomannan has also been found. Recently, a glycoprotein
with antiallergic properties, called alprogen and a novel anti-inflammatory compound, C-glucosyl
chromone, have been isolated from Aloe vera gel [ 23, 25, 26, 29].
5. Anthraquinones: A. vera provides many anthraquinones, which are phenolic compounds
traditionally known as laxatives [8, 20]. Aloe-emodin, Aloesinand barbaloin are associated to
Figure 1.2 - Components of the typical leaf structure of an Aloe plant.
(Adapted from http://www.niehs.nih.gov/health/topics/agents/aloe/
index.cfm)
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decelerate tumor growth and had been reported to have chemo-preventive effect in cancer cells
[21].
6. Fatty acids: A. vera provides 4 plant steroids, cholesterol, campesterol, β-sisosterol and lupeol.
These exhibit anti-inflammatory action and lupeol also possesses antiseptic and analgesic
properties [20].
7. Hormones: A. vera auxins and gibberellins help in wound healing and have anti-inflammatory
action [7, 20].
8. Others: A. vera contains salicylic acid that possesses anti-inflammatory and antibacterial
properties. Lignin, an apparently inert phenolic polymer, when included in topical preparations,
enhances penetrative effect of the other ingredients into the skin. Saponins are the isoprenoid
soapy substances which form about 3% of the gel and have cleansing and antiseptic properties [20].
1.2 Aloe as a pharmacological tool for cancer treatment
Albeit the widespread use of popular traditional medicine throughout the globe, Aloe species are
used for several ailments, ranging from immunomodulatory, anti-inflammatory, antiulcer,
antimicrobial and antifungal activity [7, 14, 18, 30]. One of its most popular attributes is proclaimed
anticancer activities, which have also been one of the most studied activities in this genus. Reported
studies have shown the plant´s effectiveness towards various cancer types such as liver, colon,
duodenal, skin, pancreatic, intestinal, lung and kidney, and these studies have been confirmed by
several experimental in vitro and in vivo studies [31, 32]. Aloe vera extracted components have been
proven to decelerate tumor growth, especially the anthraquinones like Aloesin, Aloe-emodin and
barbaloin [33]. These components have been reported to exert a chemo-preventive effect through the
regulation of several enzymes in the cell [33]. Aloe-emodin can induce cell apoptosis through S-phase
arrest in a dose- and time-dependent manner [33-36]. Acemannan extracted from A. vera and A.
arborescens parenchyma cells have an immunomodulatory activity and stimulate necrosis and
regression of tumors [25, 26, 37]. This polysaccharide also shows to have a significant effect on wound
healing, by accelerating the process and increasing epithelialization in burns [37].
1.3 Matrix metalloproteinases-2 and -9 as targets for cancer therapy
Matrix metalloproteinases (MMPs) are a multigene family of zinc-dependent extracellular matrix
remodeling endopeptidases involved in several pathological processes like carcinogenesis,
inflammation and auto-immune disorders. Their regulatory activity was found to be fundamental for
tumor growth and for the multistep processes leading to invasion and metastasis [38, 39]. Several studies
demonstrated that a specific group of MMPs called gelatinases (MMP-2 and MMP-9) are highly
related to cancer invasion both by degradation of the cellular matrix [40-43], and the subsequent release
of cancer cells through proteolysis [44]. These gelatinases contain a unique set of three repeats of
fibronectin that facilitate degradation of gelatinous substrates such as elastin, collagen type I and IV,
gelatin and fibrinogen (Fig.1.3) [45-47].
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Figure 1.3 - MMP-2 and MMP-9 structures (Adapted from 3http://arthritis-research.com/content/figures/ar2532-1-l.jpg).
Regarding the wide variety of molecules that can be influenced by MMPs activity, their proteolytic
function can result in both local and long-distance effects regarding the original site of product
cleavage [48]. Also, considering the range of proteins influenced by MMPs, their pivotal role in a
cancer scenario can be easily comprehended.
1.3.1 MMP inhibition aimed at cancer prevention/treatment
Since death of cancer patients is usually caused by metastization rather than caused directly by the
primary tumor itself [49, 50], and considering that cancer cell invasion is a key element in metastasis and
requires MMPs for focalized proteolysis [44, 51-53], in the last decades most anticancer drugs were
designed to target MMP activity as MMP inhibitors (MMPIs), which became an important branch of
research in both academic and industrial settings [54, 55]. So far, numerous MMP inhibitors have been
tested in in vitro assays and in animal models, as well as in clinical trials [56-58]. However MMPIs with
high specificity and low side effects have been very hard to find, and most clinical trials yielded
unsatisfactory results [50, 56, 57, 59]. A major problem associated to unspecific inhibition of MMP-9 is that
this enzyme is involved not only in various diseases but also beneficial in remodeling and scar tissue,
so its complete inhibition causes several complications in the human body [60, 61]. A distinct and more
recent strategy in the search for novel MMP-9 inhibitors is to ‘look’ among the multitude of natural
products that nature placed at our disposal. Under this context, there has been an intense search on
various biological sources to develop novel anti-cancer drugs, particularly plant-food products or
bioactive plant compounds [62, 63].
1.3.2 Can Aloe compounds target gelatinases MMP-9 and MMP-2?
Since MMP-9 and MMP-2 have been recently closely associated to inflammation, wound closure
and also the formation of metastasis in several types of cancer [64-68], the wide range activities of Aloe
suggest its target might be a link between these two diseases, i.e. inflammation and cancer. But
although it is known that MMPs play a critical role in both [69-71], to our knowledge there has been no
link established between MMP-9 inhibition induced by Aloe and cancer. So far, Aloe’s anticancer
activity and antineoplastic properties is related to three main mechanisms: antiproliferation,
immunostimulation and antioxidant effects. The antiproliferative action is known to be determined by
anthracenic and antraquinonic molecules, while the immunostimulating activity is mainly due to
acemannan [16].
Nonetheless, regarding inflammation, Aloe vera extracts are known to down regulate
metalloproteinases expression, specifically MMP-9, which actively participates in the degradation of
the extracellular matrix (ECM) when recruited by cytokines to inflammation sites [72]. So it seems
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plausible that Aloe species might inhibit MMP-9 in cancer scenarios. This type of studies can be useful
to ascertain the real effect of Aloe species on cancer and also lead to the identification of novel
anticancer strategies which can be used in prevention, for assisting chemotherapy, or even to prevent
re-incidence after surgery. Furthermore, the analysis of MMP inhibition may also be a novel
perspective which can help to understand the mechanisms of action observed in A. vera.
1.4 The Aloe vera paradigm: friend or foe?
There is an intense debate whether the so called miracle plant exhibits all the proclaimed benefits.
For example, whilst many papers described its anticancer properties [28, 31, 32, 73], other authors
suprisingly claim A. vera is in fact carcinogenic over a specific dose [23] or alert that some specific
compounds in Aloe may be severely toxic if not taken under caution [26]. Some countries such as the
USA have even forbidden the use of Aloe for consumption because of the lack of consensus towards
this species’ activities (although it is still allowed as a topic agent). This dramatic imposition is highly
disputed by communities worldwide, as the empirical experience and anecdotal results suggest that
Aloe has a high efficiency. This results in a generalized unsupervised use of Aloe, without a scientific
background. Furthermore, the phenotype similarities among species are extremely high, which induces
people to use often the wrong species. Therefore, the current unsupervised use of A. vera can result in
cases of allergies and toxic effects, and in scientific studies, can originate an erroneous evaluation of
the real effective benefits of the species [71, 74, 75].
Many reasons can be advanced to explain these contradictory reports on A. vera: first and foremost,
the overall misidentification of the Aloe genus’ species, not only because they can be erroneously
mistaken with A. vera, but also because different species with potentially different and stronger
bioactivities might be being neglected. In fact, ancient medical texts refer to A. perryi or A. ferox
instead of A. vera [1, 64] for medicinal effects. Current research also supports other Aloe species do
contain more potent bioactivities than A.vera [8]. Nonethless these species continue to be neglected. A
search on PubMed (29.09.2016) gave a total of 2689 hits for Aloe (more than 96% involving A. vera)
with only very few studies focusing on species other than A. vera (e.g. A. arborescens and A. ferox).
So it seems plausible to infer that we have barely scratched the surface in exploring these other species
as sources of pharmacological agents [8].
Secondly, in the last decades an effort has been made to isolate phytochemicals that can be used as
a single chemical entity and as an alternative to synthetic drugs. However, in the last few years a
different perspective has emerged suggesting that using crude and/or standardized extracts as opposed
to single compounds might be an advantage since each component has its major effect when acting
synergistically with other components in the plant [30, 75, 76]. In this context, it also important to refer
that there is an overall lack of consistency concerning the type of extractions to use. Some reports refer
to aqueous extracts [77]whilst others use alcoholic or organic solvents such as methanol or acetone [78,
79].  Since the main phytochemical groups range from phenolic compounds to carbohydrates, proteins,
organic and inorganic compounds as well as vitamins [7, 21, 82-84], it becomes important to test different
types of extractions to identify which provide the highest amount of bioactive compounds and allows
the better synergy among them.
1.5 Objectives
The genus Aloe has a high therapeutic potential and is often described as a cancer inhibitor.
However, the mechanisms by which different species exert their effects it is not clear and there are
many conflicting results. Also, less than 20 Aloe species have been evaluated under this perspective
and their efficacy is highly debated throughout the scientific community. The fact that their effects are
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associated with wound healing, anti-inflammatory and antitumor activities suggests that they may
influence the activity of the gelatinases MMP-9 and MMP-2. However, there is a generalized lack of
consensus towards the type of extraction one should use, the mechanism of action responsible for the
proclaimed benefits of Aloe and furthermore, if A .vera is indeed the best species for cancer prevention
/ treatment. Hence, in this work, we aimed to evaluate and compare the antitumor activity of two well-
known species of the genus Aloe: Aloe vera and Aloe arborescens and to ascertain if it is related to
MMP inhibition. With that in mind, we set out to evaluate their content in several classes of
potentially bioactive compounds, using different extraction procedures and to assess their impact on
the growth and migration of colon adenocarcinoma cells, as well as their effect on MMP-9 and MMP-
2 activities.
The specific goals were:
1 – To compare the potentially bioactive compounds in both species, Aloe vera and Aloe arborescens;
2 – To determine which is the best extraction procedure to obtain higher amounts of the bioactive
compounds;
2 – To test the effect of the same extracts in colon cancer cells, aiming to evaluate specifically cell
proliferation, cell adhesion and cell invasion rates.;
4 – To test the potential of Aloe extracts as inhibitors of the gelatinases MMP-9 and MMP-2, using
enzymatic and zymographic assays;
3 – To identify possible mechanisms of action in both Aloes, selecting the better extraction procedures
and the best species to be used in prevention and therapy in colon cancer.
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2 – Materials and Methods
2.1 Species selected and collection of plant samples
Leaves of A. vera, and A. arborescens were collected from the existing Collection of Aloe Plants of
the Instituto Superior de Agronomia (Universidade de Lisboa), probably the biggest collection of this
genus outside Africa, with over  80 species. All selected individuals had several years of existence and
were not in the flowering season. Leaf samples were collected from at least three separate individuals.
2.2 Preparation of the leaf extracts
Fresh leaves were washed with running tap water and soap and chopped into small fragments of
approximately 20 g each. Three different extraction methods were performed using different solvents:
1) 100% (v/v) methanol, 2) 50% (v/v) methanol and 3) 100 mM Tris-HCl buffer, pH 7. All extractions
were performed grinding a fragment of 20 g with the respective solvent using an ULTRA-TURRAX
T25 (IKA®Labortechnik) grinder, followed by agitation for 4h at a 4º C. Both extracts containing
methanol were evaporated in a bath at 60˚C (Kottermann) whereas the aqueous extracts were desalted
through filtration using 3 kDa membrane centricons and centrifuged at 2.000 g. All extracts were then
lyophilized (Edwards Modulyo EF4) for 24h and the obtained powder was weighted and stored at -
20ºC.
2.3 Quantification of bioactive compounds
2.3.1 Proteins
Protein quantification was performed using the standard Bradford method as described by Bradford
et al. (1976) [85]. The samples were read in a spectrophotometer Syenery HT, Bio-TEK at 595 nm and
bovine serum albumin was used as standard. All samples used in protein quantification were treated
with 1:4 (w/w) polyvinylpolypyrrolidone (PVPP) to eliminate the phenolic compounds that could
interfere with the extraction of soluble proteins [86].
2.3.2 Phenolic compounds
The phenolic compounds were quantified using the Folin-Ciocalteau reagent using gallic acid as
standard. The lyophilized powder (corresponding to 20g of fresh leaves) was treated with 10 µL of
70% (v/v) acetone, 10 µL of 0.5% (v/v) acetic acid and 80 µL of 7% (w/v) sodium carbonate.
Subsequently, a volume of 100 µL of Folin-Ciocalteau was added to the solution and the mixture was
vortexed. The solution of 200 µL was incubated for 8 min at room temperature and the absorbance
was read in a Syenery HT Bio-TEK spectrophotometer at 765 nm [87].
2.3.2.1 Anthraquinone
To 300 µL of the previous extracts, 300 µL of pure benzene were added and the resulting solution
incubated with agitation at 0˚ C bath for 30 min. It was then centrifuged at 4.500 g for 20 min at 4˚C in
a Beckman J2-21M/E centrifuge. To the recovered supernatant 500 µL of 10% (v/v) ammonia solution
were added and the absorbance read at 515 nm using Aloe blue curacao aloin as a standard [88].
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2.3.3 Total carbohydrates
Sugar quantification was performed utilizing the phenol/sulfuric acid method and mannose was
used as the standard. To the previous extracts a 4% (v/v) phenol solution was added in a proportion of
1:5 and then incubated 5 min at room temperature. Afterwards, a 1:40 proportion of sulfuric acid was
added and the absorbance read at 492 nm in the equipment mentioned above [89].
2.4 In vitro colon cancer cell assays
2.4.1 HT29 cell culture
The human colon adenocarcinoma cell line, HT29 (ECACC 85061109), obtained from a 44 year
old Caucasian female, was used throughout this work. HT29 cell lines were maintained in RPMI
medium supplemented with 10% (w/v) of heat-inactivated fetal bovine serum (FBS) and 200 mM
glutamine, 2x104 UI/mL penicillin and 20 mg/mL streptomycin at 37 °C, in a humidified atmosphere
of 5% (v/v) CO2.
2.4.2 Cell proliferation assay
HT29 cultured cells were seeded on 96-well plates (2 x 104 cells/well) and Aloe samples were
added to the growth media in different concentrations, and incubated for 24 h. After each treatment,
the extracellular media was collected, and the wells were washed with PBS to remove unattached
cells. Cell proliferation and viability was determined using the standard 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay as described by Carmichael et al. (1987) [90].
2.4.3 Minimal inhibitory concentrations (MICs)
Minimal inhibitory concentrations (MICs) were assessed in sterile 96-well plates (Greiner Bio-one,
Germany), using the micro dilution method as described before [91]. Briefly, 50 μL of RPMI medium
was added to each well. Then, 50 μL of each Aloe sample (at a 100 μg/mL protein) was added to the
first well and serially diluted 1:2 to each adjacent well, up to 10 dilutions. Subsequently, 50 μL of the
HT-29 cell suspension with a concentration of 2x105 cells/mL was added to the wells. Two controls
were performed: 1) 50 μL RPMI medium + 50 μL cell suspension, 2) 100 μL RPMI medium. Plates
were incubated for 24 h, at 37 ºC, and cell growth was measured by the MTT assay [90].
2.4.4 Cell migration assay
For cell migration analysis, the wound healing assay was performed. HT29 cells (5x105 cells/well)
were seeded in 6-well plates and allowed to reach to 80% confluence. Wounds were performed by
making a scratch across the cell monolayer to create an open gap, mimicking a wound. Cells were then
washed twice with PBS to remove floating debris. Each well was subsequently filled with fresh media
containing the samples under study, in a concentration of 100 μg/mL and allowed to grow for 48 h.
The invaded area after 48 h was calculated in each treatment and compared to the initial area at 0 h, to
determine the area covered by migrating cells into the denuded zone at the beginning of treatment.
This comparison allowed us to assess the inhibitory effect (if any) exerted by each protein fraction on
the HT29 cell migrating capacity.
~ 9 ~
2.5 MMP-9 and MMP-2 catalytic activities
2.5.1 Gelatinolytic activity
With commercial MMPs
The fluorogenic substrate dye-quenched (DQ)-gelatin was purchased from Invitrogen (Carlsbad,
CA, USA) and dissolved in water at 1 mg/mL. All solutions and dilutions were prepared in assay-
buffer (50 mM Tris-HCl buffer, pH 7.6, containing 150 mM NaCl, 5 mM CaCl2 and 0.01% v/v Tween
20). A 96-well micro-assay plate (chimney, 96-well, black) was used. Each well was loaded with 0.1
mM (for a final volume of 200 μL) MMP-9 (Sigma), to which 100 μg/mL protein of total Aloe extract
(for a final volume of 200 μL) was added, and the plate was incubated for 1 h at 37 °C. Subsequently,
DQ-gelatin (at a final concentration of 2.5 μg/mL) was added to each well and the plate was allowed
to incubate again, for 1 h. Fluorescence levels were measured read in a spectrophotometer Syenery
HT, Bio-TEK (ex. 485 nm/em. 530 nm). In each experiment, both positive (no protein fraction) and
negative (no enzyme) controls were included for all samples, to correct for possible proteolytic
activities present in the Aloe extracts. All data were corrected by subtraction of their corresponding
negative controls.
With HT29 cell culture extracellular media
The same method described above was used, with some alterations. Roughly, each well was loaded
with 100 μL of extracellular HT-29 media (containing MMP-9 and MMP-2) after exposure to the Aloe
extracts. Subsequently, DQ-gelatin (at a final concentration of 2.5 μg/mL) was added to each well (for
a final volume of 200 μL) and the plate was allowed to incubate again, for 1 h. Fluorescence levels
were measured read in a spectrophotometer Syenery HT, Bio-TEK (ex. 485 nm/em. 530 nm).
2.5.2 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
Aloe samples were treated with 100 mM Tris-HCl buffer, pH 6.8, containing 100 mM β-
mercaptoethanol, 2% (w/v) SDS, 15% (v/v) glycerol and 0.006% (w/v) m-cresol purple, and heated at
100 °C for 5 min. One-dimension electrophoresis was carried out, following the method described by
Laemmly et al. (1970) [92] in a 12,5% (w/v) acrylamide resolving gel and a 5% (w/v) acrylamide
stacking gel, and performed in a vertical electrophoresis unit at 100 V and 20 mA per gel. Gels were
fixed for 20 min in 10% (w/v) TCA, and stained in 0.25% (w/v) Coomassie Brilliant Blue R-250, 25%
(v/v) 2-propanol and 10% (v/v) acetic acid. Destaining was carried in a solution of 25% (v/v) 2-
propanol and 10% (v/v) acetic acid.
2.5.3 Reverse gelatin zymography
Reverse zymography, used to detect and quantify MMPI proteins in different samples was
performed as described in Hawkes et al. (2001) [93], with some modifications. Protein samples were
treated with zymographic buffer (313 mM Tris-HCl buffer, pH 6.8, containing 10% (w/v) SDS, 50%
(v/v) glycerol and 0.05% (w/v) bromophenol blue) and loaded in SDS-polyacrylamide (12.5% w/v
acrylamide) gels copolymerized with gelatin (1% w/v) and 1 µmol/mL MMP-9. Electrophoresis was
performed as described in 2.5.3 and the gels were washed three times in 2.5% v/v Triton X-100, for 60
min each, to remove SDS. Gels were then incubated overnight at 37 °C, with developing buffer (50
mM Tris-HCl buffer, pH 7.4, containing 5 mM CaCl2, 1 µM ZnCl2 and 0.01% w/v sodium azide),
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stained with Coomassie Brilliant Blue G-250 0.5% (w/v) in 50% (v/v) methanol and 10% (v/v) acetic
acid for 30 min, and destained with a solution of 50% (v/v) methanol, 10% (v/v) acetic acid in water.
Dark bands visible against a white background marked the MMPI-mediated inhibition of gelatin
degradation [93].
2.6 Statistical analysis
All experiments were performed in triplicate, in at least three independent times and the data are
expressed as the mean ± standard deviation (SD). SigmaPlot software (version 12.5) was used for
comparing different treatments, using one-way and two-way analysis of variance (ANOVA).  Tukey’s
test was used to compare differences between groups and the statistical differences with P value less
than 0.05 where considered statistically significant.
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3 - Results and Discussion
3.1 Selected species: A. vera and A. arborescens
Evidence has shown that certain bioactive phytochemicals are often present in more than one Aloe
species [82], an observation which inevitably supports the species-substitution hypothesis in traditional
medicine. Among the hundreds of identified Aloe species, there are two which stand out as the most
common in European countries, specifically in Portugal. A. vera, because of its huge popularity, and
A. arborescens, because it is well adapted to the Portuguese climate and is widely spread across the
public gardens as an ornamental plant. Fig. 3.1 shows representative images of these two species,
present in the herbarium collection at the Instituto Superior de Agronomia.
Figure 3.1 - Representative photos of the selected species A.arborescens and A. vera, from the herbarium collection at the
Instituto Superior de Agronomia and during the flowering season.
Although there are many differences between both species, such as morphological features, flower
color, sap color, smell and other histological features, both species are often mistaken, as many media
and anecdotal reports show.  Although there are several articles highlighting the pytochemical
composition of Aloe vera, much less is known about other species, like A. arborescens. Nonetheless A.
arborescens has been the target of some studies in the last years, some of which related to its anti-
cancer properties [16-18]. For example, A. arborescens was already proven to be effective in aiding
chemotherapy when given orally at a dose of 10 mL thrice daily of a mixture consisting of 300 g of
fresh leaves in 500 g of honey plus 40 mL of 40% (v/v) alcohol, every day without interruption, either
during or after chemotherapy [16]. In this work we aimed to compare the potential anticancer activities
between these two well-known Aloe species, A. vera and A. arborescens. With that in mind, we set out
to quantify the compounds with higher potential in cancer inhibition.
3.2 Bioactive compounds in A. vera and A. arborescens
The literature describes several compounds in A. vera [82] which can be responsible for the various
pharmacological activities previously described. The main phytochemical groups present in A. vera
have been described as phenolic compounds (anthraquinones, anthrones), carbohydrates and proteins
[7, 21, 79, 82-84]. The main components related to bioactivity in cancer and are summarized in Table 3.1.
Aloe arborescens
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Table 3.1 – Summary of the potential bioactive compounds present in Aloe vera leaves (Adapted from Park et al. (1998) and
Hamman et al. (2008)).
Class Components
Phenolic Compounds
Aloesin, 8-C-glucosyl-7-O-methyl-(S)-Aloesol, neoAloesin, 8-O-methyl-7-
hydroxylaloin A and B, isoAloeresin D, aloin A and B, Aloeresin E, Aloe-emodin
(all identified in A. vera); Aloenin, Aloenin B and 10-hydroxylaloin A (specifically
identified in A. arborescens by Park et al. (1998) [21])
Effects in cancer: antiproliferative and cytotoxic effects [16]
Carbohydrates
Pure mannan, acetylated mannan, acetylated glucomannan, glucogalactomannan,
galactan, galactogalacturan, arabinogalactan, galactoglucoarabinomannan, pectic
substance, xylan, cellulose [7]
Mannose, glucose, L-rhamnose, aldopentose [7]
Effects in cancer: immunomodulatory activity and stimulate necrosis and
regression of tumors [25, 26]
Proteins
Lectins, lectin-like substance [7]
Effects in cancer: prophylactic effect, regressed tumor size [94]
During evolution, these plants naturally evolved to produce important secondary metabolites in
order to survive their environment and its predators [95]. These different metabolites or phytochemicals
may act individually, additively or in synergy to improve the plant’s health and its chances of survival
in a given environment. Furthermore, it has been suggested that these combined actions of the
phytochemicals usually tend to increase the bioactivity of the main medicinal constituents by
influencing its assimilation in the body [77, 95]. Because of that, in this work, we not only aimed to
compare the amounts of the potentially bioactive compounds in the two selected species, but we also
wanted to select the  best extraction procedure, that would allow the highest yield in these compounds.
Therefore, we set out to quantify the major classes of bioactive compounds: proteins, total phenolic
compounds and specifically anthraquinones, and total polysaccharides.
3.2.1 The amount of bioactive compounds extracted from A. arborescens and A. vera is
influenced by the species and by the extraction procedure
The amounts of the different classes of bioactive compounds in both Aloe species are present in
Fig. 3.2. When comparing A. vera and A. arborescens we can easily identify differences between
species regarding both the extraction methods for each component and the amount of each component
per amount of fresh weight.
Proteins
Aloe plants contain around 95% (w/v) water but less than 0.1% (w/v) protein [94]. Although the
amount of total proteins present in Aloe is relatively small, its biological activities are meaningful as
evidenced by their many applications, their major part related to wound healing and several skin
diseases treatment [96-99]. Lectins are a class of proteins which have been recently identified in Aloe and
have been pointed out as important anti-cancer agents, particularly in prevention [94].
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The different extractions yielded different types proteins, according to their solubility: water-
soluble proteins, which are extracted in 100 mM Tris-HCl buffer, and the water insoluble proteins,
which encompass the membrane and wall-bound proteome and are extracted with methanol. It is
important to note that in the protein quantifications, all samples were previously treated with PVPP to
remove the majority of the phenolic components from the extract, which would otherwise interfere
with protein quantifications. For the same reason, protein quantifications were also determined
according to the method described by Bradford [85] because of the same reason. Results presented in
Fig. 3.1a corroborate the low amount of proteins present in both species, which were overall less than
0.1% (w/v) of fresh weight. Nonetheless, protein amounts and distribution varied significantly among
both species.
Figure 3.2 – Quantitative characterization of A. vera and A. arborescens considering the main phytochemical groups defined
by Hamman et al. 2008 [7]. Each extraction was performed with 20g of fresh Aloe leaves for each of the three solvents: 100mM Tris-HCl buffer, 50% (v/v) methanol and 100% (v/v) methanol. (a) Protein quantification using the Bradford method
described by Bradford et al. (1976). All samples were treated with PVPP to eliminate the phenolic compounds that could
interfere with the extraction of soluble proteins. (b) Phenolic compounds quantification with the Folin-Ciocalteau reagent and
using gallic acid as standard. (c) Total carbohydrates quantification using phenol/sulfuric acid method and mannose as the
standard. (d) Specific anthraquinone quantification (phenol component) using benzene, ammonia solution and Aloe blue
curacao aloin.* P<0.05; **P<0.001 when compared between extracts of the same species; # P<0.05; ## P<0.001 the same
extract when compared between species.
Whilst the amount of soluble protein was significantly higher (P<0.05) in A. arborescens (430
ng/g) than in A. vera (380 ng/g), A. vera presented the higher amounts of insoluble proteins than A.
arborescens (404.61 ng/g and 288.3 ng/g, respectively) (P<0.05).
Phenolic compounds
Phenolic compounds were already described as the second major class of compounds found in A.
vera [100], second only to polysaccharides (Fig. 1.3.b). Phenolic compounds present in plants, result
from their secondary metabolism and are the main group of substances responsible for most of the
plant medicinal properties, including Aloe species [27, 100, 101]. Regarding the results in Graphic 3.1.b,
corresponding to total phenols present per extraction, it is clear that the extraction with 50% (v/v)
methanol yields higher amounts of total phenolic in A. vera extraction (26.19 µg/g), whereas for A.
a
c
b
d
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arborescens the extraction with 100% (v/v) methanol yielded the highest amounts (16.48 µg/g), in a
significant manner (P<0.05). Albeit in Fig. 1.3.b A. vera presented more phenolic compounds
(P<0.05) when compared to A. arborescens, when evaluating the specific group of anthraquinones
(Fig. 1.3.d) A. arborescens had a significant higher content in the methanolic extractions.
Total carbohydrates
It is well-known that polysaccharides are abundantly represented in A.vera, being the major
compound class present in the mucilage of these plants [25, 26]. Partially acetylated mannan or
acemannan have been identified as the primary polysaccharides which are associated to the beneficial
effects of A. vera as an anticarcinogenic agent. Acemannan for example was found responsible for the
stimulation of the immune response in cancer scenarios, contributing to tumor weight reduction and
the improvement of chemotherapy drugs [102, 103].
In the present work, regarding the composition in total polysaccharides between the two species in
this work, the extraction with 50% (v/v) methanol presented a significantly higher yield than the other
two extractions (P<0.001). For example, A.vera contains 7.72 ng/g against 0.25 ng/g for 100 mM Tris-
HCl buffer and 0.14 ng/g for 100% (v/v) methanol. Similar results were found between both species
for all tree extractions (P>0.05).
Overall, these results suggest that the composition in bioactive compounds is similar in both
species, particularly in the phenolic compounds and total polysaccharides; there are significant
differences that could be important for their bioactivities, namely the higher amount of anthraquinones
and water-soluble proteins in A. arborescens when compared to A. vera extracts. A. vera nonetheless
presented higher amounts of phenolics and wall and membrane-bound proteins.
3.2.2 The majority of the phytochemical components from A. vera are better extracted in
50% (v/v) methanol
When considering the whole leaf as an organ for phytochemical extraction, the possibility to
combine several components has been suggested to potentiate its therapeutic activity [77, 95]. However,
the choice of the extraction method by which the compounds are obtained is essential. Results here
presented show that the extraction method not only influences the amount of bioactive component
extracted but it also differs among species.  Hence, for A. vera, for all compounds classes except the
proteins, the majority of the compounds were better extracted with 50% (v/v) methanol (phenolics and
polysaccharides, with P<0.05) whereas for A. arborescens the highest yields were obtained in the
100% (v/v) methanol extraction. This suggests the presence of different compounds but more
importantly, it arises the question of whether most literature using non-aqueous polar and non-polar
solvents such as ethanol, acetone etc. are using the correct extractions to yield the better bioactivities
with A. vera.
3.3 Effects of total Aloe extracts in colon cancer cells
An estimated 3.45 million new cases of cancer and 1.75 million deaths from cancer occurred in
Europe in 2012 [104], with colorectal cancer (CRC) being the second most common cause of cancer
death in the European Union [104, 105]. CRC is often highly metastatic and resistant to anticancer
treatment strategies [106], and despite the intensive research made and the significant advances in
diagnosis, screening and treatment, the overall long-term outcome in patients has not significantly
changed in the last decades; the five-year survival rate is approximately 60% [49 106].  MMP-9 inhibitors
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(MMPIs) are considered anti-angiogenic agents and metastasis deterrents for CRC, and have also been
demonstrated to effectively inhibit pre-cancer states such as colitis and other inflammatory bowel
diseases [107]. In this work, we aimed to test and compare the anticancer and MMP-9 inhibitory
potential of the selected extracts of both Aloe species under study. Hence, we selected the colon cancer
cell line HT29 for our tests, using the standard cell proliferation and cell migration assays.
Since the all extraction procedures seemed to provide different amounts of different compounds
(Fig. 3.1), and differed between species, preliminary experiments were conducted to select the best
extraction procedure to use in the HT29 cell assays. Preliminary results (see annex 1) showed that
using the cell migration wound assay, for A.vera the best results were obtained for 50% (v/v) methanol
extractions, whereas for A. arborescens there were no significant differences between 50% (v/v) or
100% (v/v) methanol extracts. Therefore, the 50% (v/v) extraction was selected to pursuit our studies.
3.3.1 Aloe extracts reduce cancer cell growth
To test if the effect of the Aloe extracts was cytotoxic to HT29 cells, and if it influenced cell
growth, we studied identical concentrations of plant extracts using a standard cell proliferation assay.
Figure 3.2 illustrates the proportion of HT29 living cells after growth in the presence of different
concentrations of Aloe extracts (50, 25 and 10 µg dry weight/mL), determined after staining with MTT
(which can only be metabolized by living cells). The results show that a 2-day exposure to the 50%
(v/v) methanol extract from both Aloe species did induce a significant reduction (P>0.001) in cancer
cell growth when compared to controls.
Furthermore, this reduction was strongly dose-dependent, with higher concentrations inducing a
significantly higher inhibition than the previous (P<0.05).  Previous reports have shown that Aloe
induces a direct inhibition of cancer cell proliferation through Aloenin-like molecules.  According to
Lissoni et al. (2009) [16], this finding is not surprising, since Aloenin and other similar molecules may
be classified within the group of anthracenic and anthraquinonic substances, whose antiproliferative
cytotoxic effects are well known [16].
Figure 3.3 - Cell proliferation assay. Cells were exposed for 48h to A. vera and A. arborescens extracts prepared with 50%
(v/v) methanol at for 48h. Cell growth was determined by the standard MTT assay. Results are expressed as the means of at
least three replicate experiments ±SD.*P<0.05 between concentrations.
Interestingly, although it has been suggested that A. vera is the Aloe species with the lowest
toxicity, our results show that there were no significant differences (P<0.001) between A. vera and A.
arborescens in all concentrations tested. Being dose-dependent, the results point to a EC50 of 25 µg
dry weight/mL for the 50% (v/v) methanol extracts. Minimal inhibitory concentrations were also
determined and results are expressed in Table 3.2.
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Table 3.2 - Minimal inhibitory concentrations for cell growth when HT29 cells were exposed to different concentrations of
A. vera and A. arborescens extracts prepared with 50% (v/v) methanol. Results are expressed in µg dry weight/mL
MIC results point to much lower inhibitory concentrations, which were nonetheless  higher inhibitory
activity for A. arborescens, with a MIC of 3.12 µg dry weight/mL, which is roughly half the MIC
determined for A.vera,
3.3.2 Aloe extracts differently reduce cancer cell invasion
Whilst the cell proliferation assay provides us with growth inhibition, cell metabolism and overall
cytotoxicity, the wound healing assay helps to evaluate the reaction of confluent cells in response to a
disruption of cell-cell contacts. What normally occurs is an increase of the growth factors
concentration at the wound margins which stimulates proliferation and migration in order to close the
opened wound [108], thus mimicking the metastatic process of cell invasion. These two processes are
extremely important when considering cancer development and have been closely related to MMP
activity, particularly MMP-9.
In the wound healing assay we set out to characterize the migratory response of HT-29 cells when
exposed to the 50% (v/v) methanol extractions of A.vera and A. arborescens. Since the EC50
concentration was 25 g/mL, we selected this concentration for the wound healing assays and the
results are expressed in Fig. 3.3. The percentage of wound closure of cells exposed to the Aloe extracts
was compared to a positive control which presented a maximum closure of 74% after 48h and to a
negative control of a known MMP-9 inhibitor, doxycycline at a concentration of 40 µg/mL. This
concentration was selected based on previous reports which show doxycycline inhibiting MMP-9
activity in other cancer scenarios [107].
Results show that all treatments induce very significant differences (P<0.001) when compared to
controls. Unlike the cell proliferation assays, significant differences were observed between the A.vera
and A.arborescens extracts (P<0.05). While A. arborescens presented a wound closure of 19% , which
was not significantly different (P>0.05) from the deoxycycline treatments, A. vera was less effective in
inhibiting cell invasiveness with 37% of wound closure, which was significantly higher than
deoxycycline [109]. These results suggest that although A.vera is the most used species and has been
attributed a lot of therapeutic benefits, regarding anti-cancer potential, it may not be as efficient as it
has been described in reducing cancer cell invasion. On the other hand, A.arborescens has also been
proven to have very good results when used as a co-adjuvant in some chemotherapeutic treatments [16]
and this might be due to its capacity to inhibit tumor invasion and cell migration [109, 110].
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Figure 3.4 – (a) Representative images of the wound healing assay on cells exposed to A. vera or A. arborescens extractions
with 50% (v/v) methanol at time 0h and after 48h of exposure. (b) Wound closure after a 48h period exposure to A.vera or
A.arborescens extractions with 50% (v/v) methanol. Doxycycline at a concentration of 40 µg/mL was used as a positive
control for metalloproteinase inhibition (Kim et al. 2005). * P<0.05; **P<0.001 when compared with positive controls; #
P<0.05; ## P<0.001 when compared to doxycycline.
3.4 Aloe extracts inhibit gelatinase activity
MMPs have been implicated in the migratory ability of cancer cells due to its capacity to degrade
the extracellular membrane. MMP-2 was the first endopeptidase recognized to degrade collagens and
to be associated with the invasive and metastatic potential of cancer cells [108]. The active form of
MMP-2 co-localize with a pro-form of MMP-9 in many types of cancer, being able to activate it, thus
increasing tumor malignancy [111, 112]. MMP-9 is associated to promotion of metastization,
angiogenesis and cell survival [112, 113, 114].
Since A. vera has been pointed to concomitantly present anti-inflammatory and anti-cancer
activities, it seems plausible to infer that MMP-9 (a known key player in both conditions) can also be a
target for Aloe’s bioactive compounds. Nonetheless, albeit there are many works on the anticancer
activities of A. vera, to our knowledge, there are no studies which correlate its anticancer activities
with MMP-9 and MMP-2 inhibition.  Also, although there has been a considerable body of research
related to the effects of A. vera on cancer cells, very few use the whole extract, and even fewer have
tested A. arborescens.  Under this context, in this work, it was also our goal to test the activities of
MMP-9 and MMP-2 in the extracellular media of the HT29 cells after exposure to 25 g/mL, using
the DQ-gelatin kit. This kit contains a quenched-die gelatin substrate, which when under proteolytic
attack, for example, in the presence of active forms of either one of the gelatinases, produces
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fluorescence. Fig. 3.5 shows the total gelatinolytic activity present in the extracellular media expressed
as a percentage of controls.
Figure 3.5 - MMP-9 and MMP-2 activities are inhibited by A. vera and A. arborescens extracts. Total gelatinolytic activity
in cell media was evaluated after the 48 h incubation of HT29 cells with Aloe extracts, using the fluorogenic gelatin assay,
DQ™-gelatin (Life Technologies), where an increase in fluorescence is proportional to enhanced gelatin degradation, caused
by MMP-9 and MMP-2 activities.  Values are expressed as percentages relative to controls and are represented as the media
 SD of at least three replicate experiments. * P<0.05.
Figure 3.5 suggests that both Aloe species could indeed inhibit the gelatinase activity in the cell
growth media, but only up to 20% being significantly similar between both species.  Since both
gelatinases MMP-9 and MP-2 are present simultaneously in the extracellular media and since there
could be specificity towards one of them, we further used gelatin zymography.  This technique uses a
regular electrophoresis (SDS-PAGE) under non-reducing conditions, to separate the extracellular
media proteins (containing MMP-9and MMP-2 among many others) by their mass, but contains
imbibed in the acrylamide matrix gelatin, the substrate for gelatinases. After incubation, the active
individualized gelatinases will induce proteolysis of the gelatin in the spot of the gel where they are
located, producing a white band in contrast to an otherwise blue gel, whereas inactive (i.e. inhibited)
gelatinases remain unaltered. Figure 3.6 shows examples of gelatin zymography of the samples used in
this work.
Figure 3.6 -MMP-9 and MMP-2 activities are inhibited by A. vera or A. arborescens extracts. Extracellular HT29 cell media
samples were subjected to a non-reducing gel electrophoresis (SDS-PAGE) in 12,5 % polyacrylamide gels supplemented
with 0.2% (w/v) gelatin from bovine skin, type B . After renaturation, MMP-9 and MMP-2 activity was stimulated by
incubation in reaction buffer (see material and methods) and the gel was stained for total protein. The presence of gelatinase
activity is observed by clear bands against a dark blue background.
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White bands are indicative of the gelatinolytic activity of the specific bands, active MMP bands,
including the pro-enzyme and its active form. In the case of the MMPs, they are usually synthesized as
zymogens (pro-MMPs), with their catalytic activity blocked by a cysteine switch and are only
activated by its removal, through limited proteolysis.  In the zymography, the pro-gelatinases also
become active because they are denaturated by the SDS, thus exposing the catalytic site (hence the
slightly higher mass of the pro-enzymes in the zymography, which still maintain the short amino acid
sequence of the cysteine switch). Hence there are two white bands for each MMP, as observed in the
controls in Fig. 3.5 gelatinase A or MMP-2 has a 72kDa molecular mass dimension whereas gelatinase
B or MMP-9 has 92kDa.
When observing the lanes of the extracellular media exposed to the Aloe extracts, we can see that,
after exposure to the Aloe extracts, MMP-9 was completely inhibited in both forms, pro-enzyme and
active form, whereas MMP-2 active form is still active, in both cases. These results suggest a stronger
inhibitory specificity towards MMP-9, in both Aloe species. Since MMP-9 is strongly related to
inflammation, wound healing and cancer invasion [41, 49, 50, 114], these results are more consistent to the
reported bioactivities of Aloe. This may also explain why only 20% of the total gelatinase activity was
inhibited. Indeed, since MMP-2 was still active in the extracellular extracts, it could still induce
proteolysis of the quenched-die gelatin.
MMP-9 specificity can be of significant importance because has been assumed that most MMPIs
are non-specific, and this is, in turn, responsible for their generalized adverse side-effects. A more
specific inhibition, targeted solely to MMP-9, particularly in colon cancer, where this MMPI might act
in situ may be of significant potential to anticancer and anti-inflammatory approaches in the
gastrointestinal diseases.
In order to understand if the observed inhibitory activities were due to direct binding of Aloe
extract components to MMP-9, we further tested its inhibitory activity towards these enzymes, using
once again the DQ-gelatin kit. Fig. 3.7 shows the MMP-9 (Sigma) activities in the presence of both
extracts, expressed in percentage of controls.
Figure 3.7 - Gelatinolitic activities of MMP-9 after exposure to ethanol extracts of several Aloe species. MMP-9 was
allowed to incubate in the presence of 25 g/mL extracts of A. arborescens and A. vera and its activity was quantified by the
DQ-gelatin assay. Results are expressed as percentage of controls. Values are the means of at least 3 replicate experiments 
SD. *P<0.05, **P<0.001.
As observed in Fig. 3.7, both Aloe extracts were able to reduce MMP-9 activity directly, but this
inhibition was higher for A. arborescens (P<0.001) than for A.vera (P<0.05). These results suggest
that the higher MMP-9 inhibitory activities in A. arborescens can be the reason for the higher
inhibition of cell invasion found for this species (Fig.3.3). However, the percentage of inhibition was
not as high as the one observed in the zymographic analysis, where MMP-9 was completely inhibited.
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This suggests a possible broader mechanism: the Aloe extracts do not only inhibit directly this enzyme,
but also might alter its expression at the DNA level. Further work should be done in order to pursuit
this hypothesis.
Nonetheless, overall, our general results suggest specific important issues: 1) the genus Aloe is able
to inhibit MMPs, 2) there are indeed differences among Aloe species and 3) possibly, A. vera is not the
most efficient Aloe species. These facts allow us to ask important questions: is all the debate and
misconception about A. vera being caused by erroneous uses of different species (more or less
efficient, or more toxic than A. vera)? And are we missing out on not testing other Aloe species, in
search for important bioactivities, which can efficiently be used in medical treatments?
The fact that Aloe species reduce MMP activity is also an important factor MMP-9 and MMP-2,
are proteolytic enzymes which can degrade the extracellular matrix components (ECMs) [64-68, 114] that
is usually closely associated to inflammation, wound closure and also the formation of metastasis in
several types of cancer [64-68]. Therefore, our discovery that Aloe species can reduce MMP activity is
consistent to inhibition of specific problems such as wound healing, inflammation and cancer, which
in fact match many of the proclaimed health benefits of Aloe, and scientific results obtained over the
years. So the following question arises: is the activity of Aloe against MMPs the reason for its
benefits? Can it be used to treat specific conditions? Further work should be pursued to answer these
questions.
4 - Conclusions
Overall, the work presented in this thesis has shown that both studied species of Aloe, i.e. A. vera
and A. arborescens present indeed a potential for inhibiting tumor growth and invasion, both by
inhibiting cell growth and invasion. The results also show that this inhibition may be associated to a
specific reduction of MMP-9 activity.
Despite having similar concentrations of various bioactive classes of compounds, A. arborescens
appears to be a more effective cancer cell invasion inhibitor than A. vera. This might be due to a
greater amount of bioactive compounds like anthraquinones present in A. arborescens, or to the
presence of specific compounds not yet identified in this species. Nonetheless, results show that in
studies related to cancer prevention or therapy using Aloe species, A. arborescens should be
considered as an effective alternative to A. vera. Furthermore, our results also highlight the importance
of the extraction procedure to obtain higher amounts of bioactive extracts, such as phenolics,
anthraquinones and polysaccharides, particularly in A.vera.
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Annex 1
1.1 Cell migration assay
For cell migration analysis, the wound healing assay was performed. HT29 cells (5x105 cells/well)
were seeded in 6-well plates and allowed to reach to 80% confluence. Wounds were performed by
making a scratch across the cell monolayer to create an open gap, mimicking a wound. Cells were then
washed twice with PBS to remove floating debris. Each well was subsequently filled with fresh media
containing the samples under study in a concentration of 100 μg/mL and allowed to grow for 48 h. The
invaded area after 48 h was calculated in each treatment and compared to the initial area at 0 h, to
determine the area covered by migrating cells into the denuded zone at the beginning of treatment.
This comparison allowed us to assess the inhibitory effect exerted by each protein fraction on the
HT29 cell migrating capacity.
Figure 1.1 – (a) Representative images of the wound healing assay of cells exposed to A. arborescens or A. vera extracts
prepared with 100 mM Tris-HCl, 50% (v/v) methanol and 100% (v/v) methanol at a time 0h and after 48h of exposure, (b)
Wound closure after a 48h period of exposure to A. arborescens or A. vera extractions with 100 mM Tris-HCl buffer, 50%
(v/v) methanol and 100% (v/v) methanol). * P<0.05; **P<0.001 when compared with controls on the same extraction; #
P<0.05; ## P<0.001 when compared between the same species on the same type of extraction.
Results show that buffer-soluble extractions did not exert any significance reduction in cell
migration when compared to controls (P>0.05), whereas in the other methanol extractions there was an
overall reduction in cell invasion induced by both species. For A. arborescens, both methanol
extractions induced a significant reduction (P<0.001) of around 80% in cancer cell inhibition, which
was similar in both types of methanol extractions. In the case of A. vera there was a higher inhibition
for 50% (v/v) methanol extracts when compared to the 100% methanol extract (P<0.05).
As there was no difference for A. arborescens and it provided the best results for A. vera, the 50%
(v/v) methanol extraction was selected for the cancer cell assays.
